Skip to main content

stock

NDRA · ENDRA Life Sciences Inc.

What ENDRA Life Sciences Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live NDRA price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on NDRA.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
1,499,838 as of 2026-08-14 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-93.8%
ROA
-74.5%

Health

Current ratio
7.1x
Debt/equity
—

Deep value

NCAV
$3.95M
NCAV per share
$2.64
Price/NCAV
Locked
NNWC
$107,429
NNWC per share
$0.07
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30——-$1.48M$159,944
S-4 filed 2026-10-02
2026-03-31——-$2.17M-$1.31M
10-Q filed 2026-05-15
2025-12-31——-$1.62M-$3.17M
S-4 filed 2026-10-02
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30——-$1.37M-$1.60M
10-Q filed 2025-11-14
2025-06-30——-$1.30M-$1.23M
S-4 filed 2026-10-02
2025-03-31——-$1.47M-$1.04M
10-Q filed 2026-05-15
2024-12-31——-$4.30M-$4.15M
S-4 filed 2026-10-02
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30——-$1.51M-$2.35M
10-Q filed 2025-11-14
Assets
$7.94M
Equity
$6.31M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$5.76M-$7.03M-$5.20M
2024-12-31—-$10.82M-$11.51M-$7.42M
2023-12-31—-$10.52M-$10.06M-$9.58M
2022-12-31—-$13.16M-$13.18M-$12.97M
2021-12-31—-$11.50M-$11.23M-$11.17M
2020-12-31$0-$11.50M-$11.73M-$10.82M
2019-12-31$0-$10.84M-$13.31M-$8.63M
2018-12-31$6,174-$9.02M-$9.80M-$7.80M
2017-12-31$351,622-$4.63M-$5.38M-$3.31M
2016-12-31$515,582-$1.79M-$2.78M—

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named NDRA, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about NDRA.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about NDRA.

nakagai

Signals on NDRA come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the NDRA board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

ENDRA Life Sciences Inc. (NDRA): SEC filings, financials and insider trades · Nakagai